Disclosed positions

Estimated from their latest filings — positions may have changed since

$64.8K

combined est. value

Stock	Shares	Price	Value	Weight	As of
SPRYARS Pharmaceuticals, Inc.	12,176	$5.32	$64.8K	100%	2026-06-12

SPRY

ARS Pharmaceuticals, Inc.

$64.8K

12,176 sh

All filings on record

Every Form 4 transaction we track for this filer

all 6buys 0sells 3

Stock	Transaction	Date	~6mo later
SPRYARS Pharmaceuticals, Inc.	Sell $250.0K · 25,000 sh	2026-06-12	—
SPRYARS Pharmaceuticals, Inc.	Exercise $37.5K · 25,000 sh	2026-06-12	—
SPRYARS Pharmaceuticals, Inc.	Sell $254.9K · 15,000 sh	2025-07-01	—
SPRYARS Pharmaceuticals, Inc.	Exercise $22.5K · 15,000 sh	2025-07-01	—
SPRYARS Pharmaceuticals, Inc.	Sell $240.0K · 15,000 sh	2025-06-18	—
SPRYARS Pharmaceuticals, Inc.	Exercise $22.5K · 15,000 sh	2025-06-18	—

SPRYSell

2026-06-12 · ARS Pharmaceuticals, Inc.

$250.0K

—

SPRYExercise

2026-06-12 · ARS Pharmaceuticals, Inc.

$37.5K

—

SPRYSell

2025-07-01 · ARS Pharmaceuticals, Inc.

$254.9K

—

SPRYExercise

2025-07-01 · ARS Pharmaceuticals, Inc.

$22.5K

—

SPRYSell

2025-06-18 · ARS Pharmaceuticals, Inc.

$240.0K

—

SPRYExercise

2025-06-18 · ARS Pharmaceuticals, Inc.

$22.5K

—

Outcomes measure each disclosed buy against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.